Thus, barasertib can induce cell cycle arrest and apoptosis in MYCNamp/TP53wt cells at much lower drug concentrations than in TP53-mutant and MYCN-non-amplified neuroblastoma cells. The gene discussed is MYCN; the disease is neuroblastoma.